D. P. Cronin-fenton, F. Søndergaard, L. A. Pedersen, J. P. Fryzek, K. Cetin et al., Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997???2006, British Journal of Cancer, vol.44, issue.7, pp.947-953, 1997.
DOI : 10.1158/1078-0432.CCR-09-0371

A. J. Walker, T. R. Card, J. West, C. Crooks, and M. J. Grainge, Incidence of venous thromboembolism in patients with cancer ??? A cohort study using linked United Kingdom databases, European Journal of Cancer, vol.49, issue.6, pp.1404-1413, 2013.
DOI : 10.1016/j.ejca.2012.10.021

J. F. Timp, S. K. Braekkan, H. H. Versteeg, and S. C. Cannegieter, Epidemiology of cancer-associated venous thrombosis, Blood, vol.122, issue.10, pp.1712-1723, 2013.
DOI : 10.1182/blood-2013-04-460121

J. S. Brand, E. Hedayati, and N. Bhoo-pathy, Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study, Cancer, vol.342, issue.3, pp.468-475, 2016.
DOI : 10.1056/NEJM200006293422604

A. J. Walker, J. West, T. R. Card, C. Crooks, C. C. Kirwan et al., When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data, Blood, vol.127, issue.7, pp.849-857, 2016.
DOI : 10.1182/blood-2015-01-625582

E. Amir, B. Seruga, S. Niraula, L. Carlsson, and A. Ocaña, Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis, JNCI: Journal of the National Cancer Institute, vol.103, issue.17, pp.1299-1309, 2011.
DOI : 10.1093/jnci/djr242

J. K. Paulus and A. S. Rosenberg, Breast cancer and thrombosis: timing matters, Blood, vol.127, issue.7, pp.793-794, 2016.
DOI : 10.1182/blood-2015-12-683482

M. Verso and G. Agnelli, Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients, Journal of Clinical Oncology, vol.21, issue.19, pp.3665-3675, 2003.
DOI : 10.1200/JCO.2003.08.008

A. Y. Lee and P. W. Kamphuisen, Epidemiology and prevention of catheter-related thrombosis in patients with cancer, Journal of Thrombosis and Haemostasis, vol.4, issue.Suppl. 6, pp.1491-1499, 2012.
DOI : 10.1002/jhm.442

D. C. Mcgee and M. K. Gould, Preventing Complications of Central Venous Catheterization, New England Journal of Medicine, vol.348, issue.12, pp.1123-1133, 2003.
DOI : 10.1056/NEJMra011883

D. Farge, H. Bounameaux, and B. Brenner, International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer, The Lancet Oncology, vol.17, issue.10, pp.452-466, 2016.
DOI : 10.1016/S1470-2045(16)30369-2

C. A. Schiffer, P. B. Mangu, and J. C. Wade, Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline, Journal of Clinical Oncology, vol.31, issue.10, pp.1357-1370, 2013.
DOI : 10.1200/JCO.2012.45.5733

P. Debourdeau, D. Farge, and M. Beckers, International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer, Journal of Thrombosis and Haemostasis, vol.9, issue.Suppl 6, pp.71-80, 2013.
DOI : 10.1111/j.1538-7836.2010.04126.x

P. Debourdeau, D. Kassab-chahmi, and G. L. Gal, 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group, Annals of Oncology, vol.20, issue.9, pp.1459-1471, 2008.
DOI : 10.1093/annonc/mdp052
URL : https://hal.archives-ouvertes.fr/ujm-00439715

W. Saber, T. Moua, and E. C. Williams, Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies, Journal of Thrombosis and Haemostasis, vol.15, issue.2, pp.312-319, 2011.
DOI : 10.1093/annonc/mdh146

C. J. Van-rooden, F. R. Rosendaal, and R. M. Barge, Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound, British Journal of Haematology, vol.114, issue.3, pp.507-512, 2003.
DOI : 10.1001/archsurg.1972.04180020014004

S. Robert, P. Poncelet, and R. Lacroix, Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?, Journal of Thrombosis and Haemostasis, vol.16, issue.1, pp.190-197, 2009.
DOI : 10.1002/cyto.a.20354

P. M. Ridker, C. H. Hennekens, K. Lindpaintner, M. J. Stampfer, P. R. Eisenberg et al., Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men, New England Journal of Medicine, vol.332, issue.14, 1995.
DOI : 10.1056/NEJM199504063321403

S. R. Poort, F. R. Rosendaal, P. H. Reitsma, and R. M. Bertina, A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, vol.88, pp.3698-3703, 1996.

C. Ay, D. Dunkler, and R. Simanek, Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study, Journal of Clinical Oncology, vol.29, issue.15, pp.2099-2103, 2011.
DOI : 10.1200/JCO.2010.32.8294

F. Horsted, J. West, and M. J. Grainge, Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis, PLoS Medicine, vol.9, issue.7, p.1001275, 2012.
DOI : 10.1371/journal.pmed.1001275.s014

H. V. Joffe, N. Kucher, V. F. Tapson, and S. Z. Goldhaber, Upper-Extremity Deep Vein Thrombosis: A Prospective Registry of 592 Patients, Circulation, vol.110, issue.12, pp.1605-1611, 2004.
DOI : 10.1161/01.CIR.0000142289.94369.D7

D. J. Kuter, Thrombotic Complications of Central Venous Catheters in Cancer Patients, The Oncologist, vol.9, issue.2, pp.207-216, 2004.
DOI : 10.1634/theoncologist.9-2-207

F. Morazin, I. Kriegel, B. Asselain, and M. C. Falcou, Thrombose symptomatique sur cath??ter veineux central de longue dur??e en oncologie??: un score de risque pr??dictif?, La Revue de M??decine Interne, vol.26, issue.4, pp.273-279, 2005.
DOI : 10.1016/j.revmed.2004.11.017

A. Y. Lee, M. N. Levine, and G. Butler, Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer, Journal of Clinical Oncology, vol.24, issue.9, pp.1404-1408, 2006.
DOI : 10.1200/JCO.2005.03.5600

M. Monreal, A. Raventos, and R. Lerma, Pulmonary embolism in patients with upper extremity DVT associated to venous central lines?a prospective study, Thromb. Haemost, vol.72, pp.548-550, 1994.

X. Ge, R. Cavallazzi, C. Li, S. M. Pan, Y. W. Wang et al., Central venous access sites for the prevention of venous thrombosis, stenosis and infection, Cochrane Database Syst. Rev, vol.24, issue.3, p.4084, 2012.
DOI : 10.1002/14651858.CD004084.pub2

A. A. Khorana, N. M. Kuderer, E. Culakova, G. H. Lyman, and C. W. Francis, Development and validation of a predictive model for chemotherapy-associated thrombosis, Blood, vol.111, issue.10, pp.4902-4907, 2008.
DOI : 10.1182/blood-2007-10-116327

E. H. Lips, R. A. Mukhtar, and C. Yau, Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer, Breast Cancer Research and Treatment, vol.25, issue.28, pp.35-43, 2012.
DOI : 10.1200/JCO.2007.10.6823

C. Chen, N. S. Weiss, P. Newcomb, W. Barlow, and E. White, Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-741, 2002.
DOI : 10.1001/jama.287.6.734

M. Inoue, H. Nakagomi, and H. Nakada, Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer, Breast Cancer, vol.121, issue.5, pp.667-672, 2017.
DOI : 10.1053/gast.2001.29611

F. R. Rosendaal, F. M. Helmerhorst, and J. P. Vandenbroucke, Female Hormones and Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.2, pp.201-210, 2002.
DOI : 10.1161/hq0202.102318

F. H. Jansen, H. M. Van-der-straaten, M. Roest, F. Haas, P. G. De-groot et al., Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis, Haematologica, vol.90, pp.499-504, 2005.

Y. Kanno, K. Kobayashi, and H. Takane, Elevation of plasma D-dimer is closely associated with venous thrombosis produced by double-lumen catheter in pre-dialysis patients, Nephrology Dialysis Transplantation, vol.22, issue.4, pp.1224-1227, 2007.
DOI : 10.1093/ndt/gfl845

J. E. Geddings and N. Mackman, Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients, Blood, vol.122, issue.11, pp.1873-1880, 2013.
DOI : 10.1182/blood-2013-04-460139

C. Wermes, M. Von-depka-prondzinski, R. Lichtinghagen, M. Barthels, K. Welte et al., Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters, European Journal of Pediatrics, vol.158, issue.S3, pp.158-143, 1999.
DOI : 10.1007/PL00014341

R. Fijnheer, B. Paijmans, L. F. Verdonck, H. K. Nieuwenhuis, M. Roest et al., Factor V Leiden in central venous catheter-associated thrombosis, British Journal of Haematology, vol.6, issue.1, pp.267-270, 2002.
DOI : 10.1016/S0140-6736(94)92939-4

C. J. Van-rooden, F. R. Rosendaal, A. E. Meinders, J. A. Van-oostayen, F. J. Van-der-meer et al., The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis, Haematologica, vol.89, pp.201-206, 2004.

M. Mandalà, G. Curigliano, and P. Bucciarelli, Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter, Annals of Oncology, vol.15, issue.4, pp.590-593, 2004.
DOI : 10.1093/annonc/mdh146

G. H. Lyman, K. Bohlke, and A. A. Khorana, Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014, Journal of Clinical Oncology, vol.33, issue.6, pp.654-656, 2015.
DOI : 10.1200/JCO.2014.59.7351

A. M. Young, L. J. Billingham, and G. Begum, Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial, The Lancet, vol.373, issue.9663, pp.567-574, 2009.
DOI : 10.1016/S0140-6736(09)60205-1

D. Cicco, M. , M. Matovic, and L. Balestreri, Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies, Annals of Oncology, vol.20, issue.12, pp.1936-1942, 2009.
DOI : 10.1093/annonc/mdp235

D. 'ambrosio, L. , M. Aglietta, and G. Grignani, Anticoagulation for Central Venous Catheters in Patients with Cancer, New England Journal of Medicine, vol.371, issue.14, pp.1362-1363, 2014.
DOI : 10.1056/NEJMc1408861